Abstract
MRI, Efficacy, and Safety of Tolebrutinib in Patients with Highly Active Disease (HAD): 2-Year Data from the Phase 2b Long-term Safety (LTS) Study (P6-3.017)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have